Introduction
Hirsute women commonly present to gynaecologists, endocrinologists, and dermatologists who evaluate them inconsistently. The aim of this article is to offer an approach to the management of the woman who presents with hirsutism, but this approach may not be appropriate for the hirsute woman who presents with another feature of hyperandro-Definition of a hirsute women "Hirsutism" is defined as the growth ofhair in a woman on the face and body which appears in the same pattern and with the same temporal development as in men. This type of hair growth is dependent on androgenic stimulation. It differs significantly from "hypertrichosis" which is uniform growth of hair over the entire body and which develops either as part of a congenital or metabolic disorder, such as anorexia nervosa and hypothyroidism, or in response to non-hormonal drugs, such as cyclosporin and minoxidil. There is, therefore, more than just a semantic difference, for although the terms are merely Latin and Greek for excessive hair growth, the use of one term rather than the other has aetiological and therapeutic implications.
The presence of hirsutism can only be determined by clinical examination of the pattern and timing of the hair growth. The natural development of an androgenic pattern of body hair has been elegantly defined by Reynolds from studies of boys passing through puberty and adolescence.' Although this pattern was established in males, the pattern of hirsutism is identical in women, the difference being only in the density of hair growth.2 In this sense a man with no body hair is as abnormal as a hairy woman.
This growth of a hirsute pattern of body hair, or more accurately, the conversion of the fine, non-pigmented vellus hairs to pigmented terminal hairs, develops in the following predictable way after puberty. The first site is the pubic area and this is followed by the axillae after an interval of about two years. Facial hair begins to appear at the same time as axillary hair; terminal hairs start at the corners of the lips and spread over the upper lip before appearing on the chin and then cheeks. Hair growth on the body follows an orderly sequence: the lower legs, thighs, forearms, abdomen, buttocks, chest, back, upper arms and shoulders. The hair shafts themselves tend to be thick, coarse, and curly.
Hypertrichosis differs from hirsutism in two respects. First, the distribution of hair over the entire body is uniform and secondly, the hair shafts themselves have a homogeneous silky smooth form. The diagnosis of hirsutism, or androgen mediated hair growth, is not consistent with this form of hair growth.
Which women are hirsute? This is possibly the most important question to ask and should be considered in terms of the interpretation of self image as influenced by racial, cultural, and social factors.
The prevalence of hirsutism is unknown and although it is commonly believed that there are variations among racial groups, there have been no formal comparisons. There are further difficulties in assessing hirsutism. First, the diagnosis of "racial hirsutism" is not distinguished from "racial hypertrichosis" and secondly, although the pattern of androgen sensitive hair growth is well known, the degree of hair growth required for a woman to become "hirsute" is not well defined. Indeed, 40% Can hirsute women be assessed by the severity of hair growth? The regulatory role of androgens in the development of body hair growth is based on the observations that prepubertally castrated males have no body hair, but that their hair grows after testosterone replacement, and that body hair diminishes after treatment with antiandrogenic drugs. There are further, as yet unidentified, factors responsible for hair growth which are required to explain variations in (i) hair density on the body, (ii) the temporal development of that hair, and (iii) among racial groups. For example, the Japanese have relatively little facial and body hair compared with Europeans. These variations are assumed to be caused by the hair follicle androgen receptor because the differential response of the hair follicle to androgens develops irrespective of the circulating androgen concentrations.6
The correlation between androgens and hair growth in hirsute women differs from that in men because the level of androgen production is lower, and consequently the level of androgenic stimulation of the follicles is submaximal. There is, therefore, only a weak correlation between the serum testosterone concentration and hair growth scores of hirsute women which may be confounded by differences in the hair follicle androgen receptor. This may explain why there are many women who are clearly hyperandrogenised but who are not hirsute. An altemative explanation for the heterogeneity in clinical presentation of hyperandrogenised women has been proposed by Kirschner et al.' They have suggested that the skin acts as a secondary androgen clearance mechanism which is only recruited after the capacity of the primary clearing organ, the liver, has been exceeded. The hair follicles are consequently enlarged only as a complication of their metabolic action in clearing androgens. Therefore, women with high hepatic clearance could still be hyperandrogenised and present with symptoms such as infertility and menstrual disorders, yet grow little body hair.
Pathophysiology of hirsutism
The hair follicles' response to androgens is only one factor in the pathogenesis of hirsutism.
Other equally important aspects include an increase of the order of three to five-fold in the blood production rate of testosterone The causes of hirsutism (table 1) have been divided into those disorders with which women will present with hirsuties and those in which hirsutism will be noted by the physician when evaluating a woman for another symptom. This is particularly important as hirsutism is quite unlikely to be the presenting feature of Cushing's disease, prolactinoma, gonadal dysgenesis or androgen treatment and, therefore, investigations for these disorders should not be considered in the first instance.
It is convenient to consider hirsute women in three diagnostic categories depending on the severity and duration of their hirsutism (table  2) Hirsutism in postmenopausal women Hirsutism in postmenopausal women is poorly understood. Hair growth on the body gradually decreases during the fifth decade4 and the women with the benign forms of premenopausal hirsutism described above do not continue to present for medical advice after the menopause. This is probably due to the involution of androgen secreting ovarian tissue. The growth of hair on the face, however, continues to increase in elderly women and this may be due to the prolonged stimulation by normal levels of adrenal androgens.
Ovarian and adrenal tumours continue to develop after the menopause and should be sought assiduously in women with high testosterone concentrations. Some postmenopausal women develop hyperthecosis-hypertrophy of the ovarian stroma. This develops in response to stimulation by the high postmeno-pausal concentrations of gonadotrophins. This can be diagnosed by the combination of high testosterone and postmenopausal gonadotrophin concentrations.
Summary
Should hirsute women be investigated? Most only need careful clinical evaluation. First, they need to be examined to determine whether they are hirsute or hypertrichotic, and for the degree of hair growth to assess the most appropriate form of treatment. Second, they need to be clinically evaluated for signs and symptoms of virilism to determine the extent of investigation needed. If virilism is absent laboratory investigation need only be minimal. As most hirsute women will have mild ovarian hyperandrogenism they will only require the appropriate tests for polycystic ovaries, and only those women who are virilised will need intensive investigation. The approach described is considered minimalist by some22; but unless a tumour is diagnosed, anti-androgen treatment will only be offered to those with severe hirsutism who want treatment. Anti-androgens will be prescribed because (i) current medical treatment is insufficiently specific to require accurate localisation of the source of excess androgen and (ii) because anti-androgens are more effective at reducing hair growth than hydrocortisone, even in late onset congenital adrenal hyperplasia. 23 
